//
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial
Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction
Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia
Lifestyle Modifications for Preventing and Treating Heart Failure
Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems